05/07/2026
Alcohol can significantly deplete vitamin B6 (pyridoxine) by reducing its absorption in the gut, increasing its loss through the kidneys, and impairing the liver’s ability to convert it into its active form. Vitamin B6 is essential for producing key neurotransmitters such as serotonin, dopamine, and GABA, which regulate mood, pleasure, stress resilience, and relaxation. When B6 levels are low, these brain chemicals can become imbalanced, leading to increased anxiety, low mood, irritability, poor sleep, and stronger cravings for alcohol as the brain seeks temporary relief. This creates a cycle where drinking further depletes B6, potentially reinforcing alcohol dependence. Supporting adequate vitamin B6 intake, alongside a balanced diet and appropriate medical or nutritional care, may help restore healthy neurotransmitter function and support recovery, although it is not a standalone treatment for alcohol addiction
Read More here …
https://www.facebook.com/share/p/1B3fgrAG4n/?mibextid=wwXIfr
We usually think of vitamins as something we get from food. A study published this year in Gut Microbes suggests that for vitamin B6, part of the supply, and part of the dopamine it helps your brain build, may come from bacteria living in your gut.
Start with the biochemistry - the active form of vitamin B6 is a molecule called PLP (pyridoxal-5'-phosphate). PLP is the required cofactor for aromatic L-amino acid decarboxylase, the enzyme that carries out the final step of dopamine synthesis: converting L-DOPA into dopamine. Without enough PLP, that last step stalls. B6 is not a bystander in the dopamine system. It is part of the machinery.
Here is what the researchers found: First, in stool samples from people with Parkinson's disease, the gut microbiome was enriched for the bacterial pathway that produces PLP. That is an association, so on its own it does not tell you which way the causation runs. So they went to controlled models.
In C. elegans (a worm) and in mice, they deleted the bacterial gene responsible for making B6 from scratch. The effect on the host was consistent: lower B6, lower dopamine, reduced activity of the dopamine-building enzymes, less tyrosine hydroxylase staining in the substantia nigra (the exact brain region that degenerates in Parkinson's), and impaired movement. When they supplemented B6, it recovered. In Parkinson's-relevant models, the bacterial B6 supply even influenced alpha-synuclein aggregation and the motor deficits tied to human LRRK2 mutations, two of the most studied features of the disease.
the host may have been leaning on the bacterial supply. Your dopamine neurons may build part of their output using B6 that your microbes manufacture, not only the B6 that arrives in your diet. That reframes a familiar nutrient. B6 is not just general "nerve support." It sits directly in the dopamine assembly line, and your gut community is one of the hands feeding it.
Why does this matter? It adds a second lever to B6 status. The usual one is intake, how much B6 is in your food and supplements. The new one is production, whether your gut community makes and delivers it. It also raises the possibility that two people with identical diets could differ in how much B6 actually reaches their tissues, depending on who lives in their gut.
This is mechanism work in worms and mice combined with a human association. It is not a human trial. It does not show that taking a B6 supplement raises dopamine in people, and it does not show that changing your microbiome treats or prevents Parkinson's. Those are the next questions, not answered findings.
There is also a genuine twist that keeps this from being a simple "more bacterial B6 is better" story. The same Parkinson's microbiomes were enriched not only for the B6 pathway but for tyrosine decarboxylase, a bacterial enzyme that can convert levodopa, the main Parkinson's medication, into dopamine down in the gut before it ever reaches the brain. That lowers how much of the drug gets where it needs to go. So the same bacterial chemistry that supports your own dopamine can also interfere with dopamine-based treatment. That is why the authors describe bacterial B6 as a context-dependent target rather than good or bad.
Some of what your brain runs on is being manufactured by the ecosystem inside you. Vitamin B6 and dopamine are one clear, well-mapped example, and this study is among the first to trace the wiring from a single bacterial gene all the way to host movement.
Kim et al., Gut Microbes 2026
